While CD8+PD-1intTIGIT+ T cells are found in tumors of all HCC patients, TIGIT-expressing CD8+PD-1hi TILs are present in a subset of HCC patients (31) and are associated with poor prognosis (68), supporting their poor anti-tumor functions. Here, CD8A is linked to hepatocellular carcinoma.